Table 5 Kaplan–Meier postoperative survival analysis (log-rank test) according to clinical-pathological factors
From: Time-varying pattern of recurrence risk for localized melanoma in China
Variable | mRFS(months) | P |
|---|---|---|
Sex | 0.135 | |
Male | 12 | |
Female | 13 | |
Age | 0.854 | |
≤ 65 | 13 | |
> 65 | 12 | |
Pathological type | 0.001 | |
Mucosal melanoma | 11 | |
Cutaneous melanoma | 14 | |
Clinical subtypes for cutaneous melanoma | 0.009 | |
Acral | 16 | |
CSD/N-CSD | 12 | |
Primary site for mucosal melanoma | 0.798 | |
Head and neck | 11 | |
Genitourinary tract | 12 | |
Digestive tract | 12 | |
Respiratory tract | 13 | |
Primary tumor thickness for cutaneous melanoma | < 0.01 | |
≤ 4.0 mm | 30 | |
> 4.0 mm | 12 | |
Ulceration for cutaneous melanoma | 0.012 | |
Present | 13 | |
Absent | 15 | |
Regional lymph node metastasis for cutaneous melanoma | < 0.001 | |
Yes | 8 | |
No | 24 | |
Stage for cutaneous melanoma | < 0.001 | |
I | 82 | |
II | 20 | |
III | 8 | |
Wound infection for cutaneous melanoma | < 0.001 | |
Yes | 6 | |
No | 15 | |
Adjuvant therapy for cutaneous melanoma | 0.021 | |
Yes | 15 | |
No | 13 | |
Adjuvant therapy for mucosal melanoma | 0.302 | |
Yes | 12 | |
No | 11 | |